• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tau蛋白病细胞培养模型中的tau蛋白聚集与毒性

Tau aggregation and toxicity in a cell culture model of tauopathy.

作者信息

Bandyopadhyay Bhaswati, Li Guibin, Yin Haishan, Kuret Jeff

机构信息

Center for Molecular Neurobiology, the Department of Molecular and Cellular Biochemistry, Ohio State University, Columbus 43210, USA.

出版信息

J Biol Chem. 2007 Jun 1;282(22):16454-64. doi: 10.1074/jbc.M700192200. Epub 2007 Apr 11.

DOI:10.1074/jbc.M700192200
PMID:17428800
Abstract

Intracellular aggregation of the microtubule-associated protein tau into filamentous inclusions is a defining characteristic of Alzheimer disease. Because appearance of tau-aggregate bearing lesions correlates with both cognitive decline and neurodegeneration, it has been hypothesized that tau aggregation may be directly toxic to cells that harbor them. Testing this hypothesis in cell culture has been complicated by the resistance of full-length tau isoforms to aggregation over experimentally tractable time periods. To overcome this limitation, a small-molecule agonist of the tau aggregation reaction, Congo red, was used to drive aggregation within HEK-293 cells expressing full-length tau isoform htau40. Formation of detergent-insoluble aggregates was both time and agonist concentration dependent. At 10 microM Congo red, detergent-insoluble aggregates appeared with pseudo-first order kinetics and a half-life of approximately 5 days. By 7 days in culture, total tau levels increased 2-fold, with approximately 30% of total tau converted into detergent-insoluble aggregates. Agonist addition also led to rapid losses in the tubulin binding activity of tau, although tau was not hyperphosphorylated as judged by occupancy of phosphorylation sites Ser396/Ser404. Tau aggregation was associated with decreased viability as detected by ToPro-3 uptake. The results, which establish a new approach for analysis of tau aggregation in cells independent of tau hyperphosphorylation, suggest that conformational changes associated with aggregation are incompatible with microtubule binding, and that toxicity associated with intracellular tau aggregation is not acute but develops over a period of days.

摘要

微管相关蛋白tau在细胞内聚集成丝状内含物是阿尔茨海默病的一个决定性特征。由于携带tau聚集物的病变出现与认知能力下降和神经退行性变均相关,因此有人提出tau聚集可能对含有它们的细胞具有直接毒性。在细胞培养中测试这一假设一直很复杂,因为全长tau异构体在实验可控的时间段内难以聚集。为了克服这一限制,使用tau聚集反应的小分子激动剂刚果红来驱动表达全长tau异构体htau40的HEK-293细胞内的聚集。去污剂不溶性聚集体的形成既依赖时间也依赖激动剂浓度。在10 microM刚果红存在下,去污剂不溶性聚集体以准一级动力学出现,半衰期约为5天。培养7天时,总tau水平增加了2倍,约30%的总tau转化为去污剂不溶性聚集体。添加激动剂还导致tau的微管蛋白结合活性迅速丧失,尽管根据磷酸化位点Ser396/Ser404的占据情况判断tau没有过度磷酸化。通过ToPro-3摄取检测发现,tau聚集与细胞活力下降有关。这些结果建立了一种独立于tau过度磷酸化分析细胞内tau聚集的新方法,表明与聚集相关的构象变化与微管结合不相容,并且细胞内tau聚集相关的毒性不是急性的,而是在数天内逐渐发展的。

相似文献

1
Tau aggregation and toxicity in a cell culture model of tauopathy.tau蛋白病细胞培养模型中的tau蛋白聚集与毒性
J Biol Chem. 2007 Jun 1;282(22):16454-64. doi: 10.1074/jbc.M700192200. Epub 2007 Apr 11.
2
Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation.位点特异性磷酸化和半胱天冬酶切割对tau与微管的相互作用及tau聚集有不同影响。
J Biol Chem. 2006 Jul 14;281(28):19107-14. doi: 10.1074/jbc.M511697200. Epub 2006 May 10.
3
Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs.Tau重复结构域在tau蛋白病细胞模型中的可诱导表达:聚集对细胞有毒性,但可被抑制剂药物逆转。
J Biol Chem. 2006 Jan 13;281(2):1205-14. doi: 10.1074/jbc.M507753200. Epub 2005 Oct 24.
4
Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.酪蛋白激酶1δ使tau蛋白磷酸化并破坏其与微管的结合。
J Biol Chem. 2004 Apr 16;279(16):15938-45. doi: 10.1074/jbc.M314116200. Epub 2004 Feb 2.
5
The acetylation of tau inhibits its function and promotes pathological tau aggregation.tau 蛋白乙酰化会抑制其功能,并促进病理性 tau 聚集。
Nat Commun. 2011;2:252. doi: 10.1038/ncomms1255.
6
Molecular mechanism of tau aggregation induced by anionic and cationic dyes.阴离子和阳离子染料诱导 tau 聚集的分子机制。
J Alzheimers Dis. 2013;35(2):319-34. doi: 10.3233/JAD-121765.
7
Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls.介导蛋白质聚集和细胞毒性的蛋白质使阿尔茨海默病患者的海马体有别于正常对照。
Aging Cell. 2016 Oct;15(5):924-39. doi: 10.1111/acel.12501. Epub 2016 Jul 23.
8
Inhibition of microtubule assembly competent tubulin synthesis leads to accumulation of phosphorylated tau in neuronal cell bodies.微管组装的抑制导致有能力合成微管的微管蛋白在神经元胞体中的积累,进而导致磷酸化 tau 的积累。
Biochem Biophys Res Commun. 2020 Jan 15;521(3):779-785. doi: 10.1016/j.bbrc.2019.10.191. Epub 2019 Nov 5.
9
Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.tau蛋白酪氨酸磷酸化的增加与tau蛋白聚集体的形成相关。
Brain Res Mol Brain Res. 2005 Aug 18;138(2):135-44. doi: 10.1016/j.molbrainres.2005.04.015.
10
Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules.Tau蛋白的阿尔茨海默病特异性磷酸化表位会干扰微管蛋白的组装,但不影响其与微管的结合。
FASEB J. 2009 Apr;23(4):1146-52. doi: 10.1096/fj.08-121590. Epub 2008 Dec 12.

引用本文的文献

1
Tau aggregation induces cell death in iPSC-derived neurons.Tau蛋白聚集在诱导多能干细胞衍生的神经元中引发细胞死亡。
Aging Brain. 2025 Apr 11;7:100136. doi: 10.1016/j.nbas.2025.100136. eCollection 2025.
2
Overexpression of TECPR1 improved cognitive function of P301S-tau mice via activation of autophagy in the early and late process.TECPR1的过表达通过在早期和晚期过程中激活自噬改善了P301S- tau小鼠的认知功能。
Aging Cell. 2025 Mar;24(3):e14404. doi: 10.1111/acel.14404. Epub 2024 Nov 7.
3
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges.
tau 蛋白聚集之谜:机制见解与未来挑战。
Int J Mol Sci. 2024 May 2;25(9):4969. doi: 10.3390/ijms25094969.
4
Abnormal Hyperphosphorylation of Tau in Canine Immune-mediated Meningoencephalitis.犬免疫介导性脑膜脑炎中 Tau 的异常过度磷酸化。
In Vivo. 2023 May-Jun;37(3):1065-1076. doi: 10.21873/invivo.13181.
5
Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?迈向 Tau 介导的神经退行性变疾病中 Tau 病理的机制模型:我们可以从基于细胞的体外分析中学到什么?
Int J Mol Sci. 2022 Sep 29;23(19):11527. doi: 10.3390/ijms231911527.
6
A Combined Cell-Worm Approach to Search for Compounds Counteracting the Toxicity of Tau Oligomers In Vivo.一种结合细胞-线虫的方法,用于寻找对抗体内 Tau 寡聚物毒性的化合物。
Int J Mol Sci. 2022 Sep 24;23(19):11277. doi: 10.3390/ijms231911277.
7
Populations of Tau Conformers Drive Prion-like Strain Effects in Alzheimer's Disease and Related Dementias.tau 构象异构体种群驱动阿尔茨海默病及相关痴呆症中的朊病毒样菌株效应。
Cells. 2022 Sep 26;11(19):2997. doi: 10.3390/cells11192997.
8
Prion-like strain effects in tauopathies.tau 病中的朊病毒样菌株效应。
Cell Tissue Res. 2023 Apr;392(1):179-199. doi: 10.1007/s00441-022-03620-1. Epub 2022 Apr 23.
9
A human tau seeded neuronal cell model recapitulates molecular responses associated with Alzheimer's disease.一种人类 tau 种子化神经元细胞模型再现了与阿尔茨海默病相关的分子反应。
Sci Rep. 2022 Feb 17;12(1):2673. doi: 10.1038/s41598-022-06411-4.
10
Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases.针对淀粉样蛋白的适体及其在神经退行性疾病中的新兴作用。
J Biol Chem. 2022 Jan;298(1):101478. doi: 10.1016/j.jbc.2021.101478. Epub 2021 Dec 9.